S. R. Schill & Associates cut its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 55.5% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 2,408 shares of the healthcare product maker’s stock after selling 3,001 shares during the quarter. S. […] Read this story